Keyword: DSM Pharmaceutical Products

News

Ardian Acquires ES and IM from DPx Holdings

23.07.2015 - Austrian private equity investor Ardian has acquired Exclusive Synthesis (ES) and Maleic Anhydride Intermediates & Specialties (IM) from Linz-based DPx Holdings for an undisclosed...

Strategy & Management

CPhI 2014 Experts Statements: Dr. Lukas Utiger, President and CEO, DSM Pharmaceutical Products

01.10.2014 - 1. What roles do contract research organizations (CROs) and contract manufacturing organizations (CMOs) play in the drug discovery/development value chain today, and how will their...

Strategy & Management

Today’s Challenges, Tomorrow’s Excellence

01.10.2014 - Pharmaceutical companies have outsourced several critical steps in the discovery and development of new drugs and the scale-up of processes and the manufacturing of APIs. Pharma...

Plant Construction & Process Technology

United in Philosophy and Approach

11.09.2013 - Smooth Connection — Custom manufacturing isn't as easy as filling an order and calling it a day. The gears that interlink a CMO and its customer have to be well oiled and a perfect...

News

DSM Opens cGMP Biopharmaceutical Manufacturing Operation in Brisbane, Australia

25.04.2013 - DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics...

News

DSM Signs Master Supply Agreement with Eisai

06.03.2013 - DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, today announced the signing of a 3 year master supply agreement with Eisai, based in...

News

Almac, DSM Collaboration Agreement in Biocatalysis Continues with Success

19.02.2013 - In October 2012, Almac announced a collaboration agreement with DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM in the field of...

News

DSM Announces License Agreement with Amgen

16.01.2013 - DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that it has signed a non-exclusive license agreement with Amgen for...